GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (XCNQ:AIAI) » Definitions » Days Sales Outstanding

NetraMark Holdings (XCNQ:AIAI) Days Sales Outstanding : 69.88 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Days Sales Outstanding?

NetraMark Holdings's average Accounts Receivable for the three months ended in Mar. 2024 was C$0.17 Mil. NetraMark Holdings's Revenue for the three months ended in Mar. 2024 was C$0.22 Mil. Hence, NetraMark Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 69.88.

The historical rank and industry rank for NetraMark Holdings's Days Sales Outstanding or its related term are showing as below:

XCNQ:AIAI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.84   Med: 29.33   Max: 279.5
Current: 279.5

During the past 4 years, NetraMark Holdings's highest Days Sales Outstanding was 279.50. The lowest was 25.84. And the median was 29.33.

XCNQ:AIAI's Days Sales Outstanding is ranked worse than
96.73% of 642 companies
in the Healthcare Providers & Services industry
Industry Median: 46.435 vs XCNQ:AIAI: 279.50

NetraMark Holdings's Days Sales Outstanding declined from Dec. 2022 (730.00) to Mar. 2024 (69.88).


NetraMark Holdings Days Sales Outstanding Historical Data

The historical data trend for NetraMark Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Days Sales Outstanding Chart

NetraMark Holdings Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Days Sales Outstanding
- - 25.84 32.81

NetraMark Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 730.00 - - - 69.88

Competitive Comparison of NetraMark Holdings's Days Sales Outstanding

For the Health Information Services subindustry, NetraMark Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NetraMark Holdings's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NetraMark Holdings's Days Sales Outstanding falls into.



NetraMark Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NetraMark Holdings's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

Days Sales Outstanding (A: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (0.008 + 0) / 1 ) / 0.089*365
=0.008 / 0.089*365
=32.81

NetraMark Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0 + 0.17) / 1 ) / 0.222*365 / 4
=0.17 / 0.222*365 / 4
=69.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NetraMark Holdings  (XCNQ:AIAI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


NetraMark Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


NetraMark Holdings (XCNQ:AIAI) Business Description

Traded in Other Exchanges
Address
1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
NetraMark Holdings Inc is focused on the application of a totally unique Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.
Executives
Andrew Parks Director

NetraMark Holdings (XCNQ:AIAI) Headlines

No Headlines